Tianan Pharmaceutical Co Stock Price To Earning
Tianan Pharmaceutical Co fundamentals help investors to digest information that contributes to Tianan Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Tianan Pink Sheet. The fundamental analysis module provides a way to measure Tianan Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tianan Pharmaceutical pink sheet.
Tianan |
Tianan Pharmaceutical Co Company Price To Earning Analysis
Tianan Pharmaceutical's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Tianan Pharmaceutical Price To Earning | 0.15 X |
Most of Tianan Pharmaceutical's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tianan Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, Tianan Pharmaceutical Co has a Price To Earning of 0.15 times. This is 99.42% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to earning for all United States stocks is 99.48% higher than that of the company.
Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
All Next | Launch Module |
Tianan Fundamentals
Return On Equity | 0.25 | |||
Return On Asset | 0.18 | |||
Profit Margin | 0.30 % | |||
Operating Margin | 0.36 % | |||
Current Valuation | 979.64 K | |||
Price To Earning | 0.15 X | |||
Price To Book | 1.20 X | |||
Price To Sales | 1.62 X | |||
Revenue | 10.65 M | |||
Gross Profit | 7.3 M | |||
EBITDA | 4.31 M | |||
Net Income | 3.14 M | |||
Cash And Equivalents | 8.23 M | |||
Cash Per Share | 0.59 X | |||
Current Ratio | 14.23 X | |||
Book Value Per Share | 1.03 X | |||
Cash Flow From Operations | 2.56 M | |||
Earnings Per Share | 0.01 X | |||
Number Of Employees | 16 | |||
Beta | 0.86 | |||
Market Capitalization | 17.29 M | |||
Total Asset | 15.38 M | |||
Retained Earnings | 4.96 M | |||
Working Capital | 11.29 M | |||
Current Asset | 12.14 M | |||
Current Liabilities | 853 K | |||
Net Asset | 15.38 M |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Tianan Pink Sheet analysis
When running Tianan Pharmaceutical's price analysis, check to measure Tianan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tianan Pharmaceutical is operating at the current time. Most of Tianan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Tianan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tianan Pharmaceutical's price. Additionally, you may evaluate how the addition of Tianan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |